RxDoctor Payments DataLook up a doctor →

Cecilia Vicuna Keady

Family Medicine · Charlestown, NHNPI 1558334656

Payments from drug & device makers

$12,798in general payments, 2019–2025

Across 558 payments — averaging $22.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Boehringer Ingelheim$2K
  • AstraZeneca$2K
  • Merz North America, Inc.$793
  • Pfizer$729
  • Lilly USA, LLC$679
  • plus $5K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)111$2,247
Boehringer Ingelheim16$1,825
AstraZeneca80$1,521
Merz North America, Inc.8$793
Pfizer50$729
Lilly USA, LLC41$679
Novo Nordisk34$665
Amgen(2 entities)22$463
GSK24$404
Astellas Pharma US Inc9$331
Teva Pharmaceuticals USA, Inc.20$327
Takeda Pharmaceuticals U.S.A., Inc.15$287
Amarin Pharma, Inc.14$271
Biohaven Pharmaceuticals, Inc.11$186
Eisai Inc.10$184
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$165
Regeneron Healthcare Solutions, Inc.6$157
Otsuka America Pharmaceutical, Inc.7$138
Merck6$117
Bayer5$117
Exact Sciences5$109
Novartis4$98
Bardy Diagnostics, Inc.5$90
Vanda Pharmaceuticals Inc.2$70
Collegium Pharmaceutical, Inc.4$67
Biodelivery Sciences International, Inc.4$64
Biogen3$64
Johnson & Johnson2$61
Medtronic2$60
Supernus Pharmaceuticals, Inc.4$53
Alkermes, Inc.3$46
Organogenesis Inc.2$44
Baxter Healthcare1$43
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$38
Abbott2$38
Dexcom, Inc.2$36
Biohaven Pharmaceutical Holding Company Ltd.2$32
Ascendis Pharma Endocrinology Inc1$28
Esperion Therapeutics, Inc.1$24
Sunovion Pharmaceuticals Inc.2$23
Organon1$21
Paratek Pharmaceuticals, Inc.1$20
Sanofi Pasteur Inc.1$18
E.r. Squibb & Sons, L.L.C.1$17
Xeris Pharmaceuticals, Inc.1$15
Neurocrine Biosciences, Inc.1$15

How this compares

$12,798 in reported general payments places this provider in the 95th percentile of 397 family medicine providers in New Hampshire.

See all family medicine providers in New Hampshire →

Medicare billing

Part B allowed, 2024
$246,432
Medicare patients
286
Services billed
4,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Charlestown

See the full list for New Hampshire →

Where these figures come from

Is this you, or does something look wrong? →